| Basics |
| Company: |
Humacyte, Inc. Common Stock |
| IPO Date: |
November 30, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$455.49M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.20 | 3.80%
|
| Avg Daily Range (30 D): |
$0.11 | 2.50%
|
| Avg Daily Range (90 D): |
$0.17 | 3.60%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.07M |
| Avg Daily Volume (30 D): |
1.79M |
| Avg Daily Volume (90 D): |
3.5M |
| Trade Size |
| Avg Trade Size (Sh.): |
141 |
| Avg Trade Size (Sh.) (30 D): |
153 |
| Avg Trade Size (Sh.) (90 D): |
174 |
| Institutional Trades |
| Total Inst.Trades: |
261 |
| Avg Inst. Trade: |
$1.46M |
| Avg Inst. Trade (30 D): |
$.92M |
| Avg Inst. Trade (90 D): |
$1.07M |
| Avg Inst. Trade Volume: |
.27M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.55M |
| Avg Closing Trade (30 D): |
$.92M |
| Avg Closing Trade (90 D): |
$.99M |
| Avg Closing Volume: |
286.89K |
|
|
|
|
| News |
Jan 21, 2025 @ 3:44 PM
DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The ...
Source: The Law Offices Of Frank R. Cruz
|
Jan 17, 2025 @ 5:28 PM
HUMA Investors Have Opportunity to Lead Humacyte, ...
Source: Business Wire
|
Jan 17, 2025 @ 3:47 PM
HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM,...
Source: N/A
|
Jan 13, 2025 @ 5:14 PM
Humacyte, Inc. (HUMA) Investors Who Lost Money Hav...
Source: Prnewswire
|
Jan 13, 2025 @ 3:08 PM
HUMA Investors Have Opportunity to Lead Humacyte, ...
Source: Prnewswire
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-1.34
|
$-.33
|
$-.48
|
|
Diluted EPS
|
$-1.34
|
$-.33
|
$-.48
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -152.87M
|
$ -39.2M
|
$ -56.66M
|
|
Operating Income / Loss
|
$ -112.49M
|
$ -30.23M
|
$ -29.5M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -29.42M
|
$ -22.99M
|
$ -21.94M
|
|
PE Ratio
|
|
|
|
|
